Government ❯Health ❯Regulatory Agencies

FDA

Drug Approval Process Generative AI Fees

FDA launches AI assistant Elsa early as staff flag readiness issues

Some employees caution that Elsa may have been rushed before reaching full functionality

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues